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In Europe; an estimated 
446,800 cases 
of colorectal cancer are 
diagnosed yearly1.  
 
One of the most 
common cancers among 
the elderly – it will 
remain a major public 
health concern as the 
population ages. 
Aim 
•Assess trends of colorectal cancer survival in Malta over a 15 year 
period by the demographic features of the population 
Population 
•Maltese residents diagnosed with colorectal cancer from 1995 to 2009 and 
followed up to end 2010 
•2463 participants included in the study (97%) 
Method 
•Cohort method for five year relative survival using national cancer registry data 
and annual population life tables.  
•Generalized linear models with a poisson distribution and link function were used 
to model the collapsed relative survival data2. 
•  Excess mortality risk ratios calculated as a function of follow up time, year of 
diagnosis, age at diagnosis, region of residence and gender.  
Conclusions 
 
• While improvements have been made in survival over the past 15 years, a gap in 
survival for older and younger patients remains. 
 
• Improving the knowledge of this target group to increase screening participation will 
help early diagnosis 
 
• Five year relative survival for all 
patients is 53.6% (95% CI 51.1 – 56.1).   
 
• Risk ratios show a significant reduction 
of 17% in risk of mortality for patients 
diagnosed in 2005 – 2009 compared to 
those in 1995 –1999 (p=0.024, 95% CI 
0.71 – 0.98).  
 
 
• In the first year of follow up patients aged 55 to 64 have a 1.57 (p=0.003, 95% CI 1.17 
– 2.11) greater risk of death when compared to those aged less than 55 while those 
aged75+ are 2.72 times more likely to die before the end of the first year of follow 
up(p<0.001, 95% CI;2.05 – 3.6)  
 
• Across all ages, risk of mortality is highest in the first year of follow up. Patients 
diagnosed at age 75+who survive the first year after follow-up, can expect their 
relative excess risk of death to drop by 71% in the second year (p<0.001, 95% CI 0.20 
– 0.42) 
Results 
Key Findings 
 
Reduction in risk of 
mortality for 
patients diagnosed 
in  
2005 – 2009 
compared to  
1995 – 1999 
 
There are no 
differences by 
gender and region 
of residence. 
 
Age at diagnosis 
and follow up time 
are significantly 
associated with 
excess risk of 
mortality.  
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